Monro vs Valvoline
MNRO and VVV side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MNRO and VVV compare
Valvoline is the larger company, worth 11 times as much as Monro ($4.1B against $374M).
Valvoline grew revenue faster over the last twelve months (16.1% versus −4.4% for Monro).
Valvoline keeps more of each dollar of sales as profit, with a net margin of 5.2% compared with 0.07% at Monro.
Monro pays a dividend yielding 9.4%; Valvoline does not pay one.
Monro scores higher on the StockData Score (11 against 9 for Valvoline), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MNRO | VVV |
|---|---|---|
| Size and price | ||
| Market cap | $374M | $4.1B |
| Share price | $11.95 | $32.29 |
| Change, 1 year | −20.7% | −1.3% |
| Change, 5 years | −81.0% | −5.8% |
| Beta (5Y) | 0.95 | 0.81 |
| Employees | 6,440 | 11K |
| StockData Score | ||
| Total score | 11 (better) | 9 |
| Valuation score | 4 (better) | 1 |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 1 | 1 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | – | 40.9× |
| P/S | 0.3× (better) | 2.1× |
| P/B | – | 9.9× |
| EV/EBITDA | 6.1× (better) | 18.7× |
| P/FCF | 30.1× (better) | 30.4× |
| FCF yield | 3.3% (better) | 3.3% |
| Fair value | $21.71 | $19.95 |
| Margin of safety | 45.0% (better) | −61.9% |
| Growth | ||
| Revenue growth (TTM) | −4.4% | 16.1% (better) |
| Revenue growth, 5Y average | 0.55% | 18.7% (better) |
| Net income growth (TTM) | – | −63.5% |
| EPS growth (TTM) | – | −63.3% |
| EPS growth, 5Y average | −50.5% | −0.60% (better) |
| Profitability | ||
| Gross margin | 34.8% | 38.3% (better) |
| Operating margin | 1.7% | 15.3% (better) |
| Net margin | 0.07% | 5.2% (better) |
| FCF margin | 1.1% | 6.9% (better) |
| Return on equity | – | 27.8% |
| Return on invested capital | – | 10.9% |
| Financial health | ||
| Debt / equity | – | 3.84 |
| Net debt / EBITDA | 1.49 (better) | 5.04 |
| Current ratio | 0.48 | 0.70 (better) |
| Altman Z-score | 1.32 | 1.75 (better) |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 9.4% | – |
| Payout ratio | 4386% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 4.9% | – |
| Buyback yield | – | 0.00% |
| Shareholder yield | 9.4% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 108% | 117% |
| Held by insiders | 30.7% | 0.33% |
| Insider net buying, 12 months | $21.3M (better) | $308K |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 34.9% | 12.1% |
Go deeper
- MNRO stock overview
- MNRO income statement
- MNRO valuation and score
- VVV stock overview
- VVV income statement
- VVV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.